Cardiometabolic Risk Factors Increase Likelihood of Liver Fibrosis More in Women Than Men

Medically reviewed by Drugs.com

via HealthDay

FRIDAY, March 13, 2026 -- Women with certain cardiometabolic risk factors face a greater increase in risk for liver fibrosis than men with the same risk factors, according to a study published online March 9 in JAMA Network Open.

Somaya Albhaisi, M.B.B.Ch., from University of Southern California (USC) in Los Angeles, and colleagues examined sex differences in the associations between cardiometabolic risk factors and significant liver fibrosis. The analysis included 5,981 U.S. adults participating in the National Health and Nutrition Examination Survey (2017 to 2020).

The researchers found that the prevalence of significant fibrosis was 6.9 percent in women and 10.7 percent in men. For the association with significant fibrosis, the point estimates were significantly greater in women than men for high waist circumference (adjusted odds ratio [aOR], 13.45 versus 4.44), glucose intolerance (aOR, 2.94 versus 1.51), and the presence of two or more cardiometabolic risk factors (aOR, 10.22 versus 2.87).

"We’re seeing that women are progressing more quickly than men to liver fibrosis once liver disease is established -- and our findings suggest that cardiometabolic risks may be part of the story," coauthor Jennifer Dodge, also from USC, said in a statement. "These findings are a reminder for both clinicians and the public that managing these cardiometabolic risk factors [is] not just important for heart disease, but also for liver disease."

One author disclosed financial ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords